Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vanta Bioscience

2010 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
540729 STOCK SYMBOL
$2.29 SHARE PRICE (As of Friday Closing)
Description

Vanta Bioscience Ltd is a full-service pre-clinical contract research organization. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Stock Exchange
BOM
Primary Office
  • 600 East Court Avenue
  • Des Moines, IA 50309
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vanta Bioscience’s full profile, request a free trial.

Vanta Bioscience Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.69 - $2.80 $14.4M $2.46 7.12K 6.31M

Vanta Bioscience Financials Summary

In Thousands,
USD
TTM
30-Sep-2018
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 7,741 5,538
Revenue 1,429 618 0
EBITDA 365 163 0
Net Income 52 4 0
Total Assets 4,125 4,484 2,120
Total Debt 1,597 1,733 1,159
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Vanta Bioscience Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vanta Bioscience‘s full profile, request access.

Request full access to PitchBook

Vanta Bioscience Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clinipace Worldwide Private Equity-Backed Morrisville, NC 000 00000 0000000 0000 00000
0000 000000 Formerly PE-Backed Shanghai, China 00000 00.000 0000 00.000
To view this company’s complete list of competitors, request access »